Select Publications
Conference Papers
2018, 'Pulmonary Effects of Immediate Versus Deferred Antriretroviral Treatment Initiation: Final Follow-Up Results from the Randomized Strategic Timing of Antiretroviral Treatment (START) Pulmonary Substudy', in AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMER THORACIC SOC, CA, San Diego, presented at International Conference of the American-Thoracic-Society, CA, San Diego, 18 May 2018 - 23 May 2018
,2016, 'Technical rehearsal of tritium operation at JET', in FUSION ENGINEERING AND DESIGN, ELSEVIER SCIENCE SA, CZECH REPUBLIC, Prague, pp. 196 - 200, presented at 29th Symposium on Fusion Technology (SOFT), CZECH REPUBLIC, Prague, 05 September 2016 - 09 September 2016, http://dx.doi.org/10.1016/j.fusengdes.2017.01.056
,2016, '"HIV-1 controllers" - what's their secret?', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 74 - 74, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383610400148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Fc gamma R ectodomain probes measure anti-viral IgG effector function', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 1256 - 1257, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000391563600040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Assessment of the impact of early ART on sexual behaviour in INSIGHT strategic timing of antiretroviral treatment (START) trial', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000395394300243&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2015, 'PRE-THERAPY INFLAMMATION/COAGULATION ACTIVATION AND LONG-TERM CD4 RESPONSE TO ANTIRETROVIRAL THERAPY', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A73 - A73, http://dx.doi.org/10.1136/sextrans-2015-052270.195
,2013, 'How occupational therapy can enhance an improving access to psychological therapy service', in BRITISH JOURNAL OF OCCUPATIONAL THERAPY, SAGE PUBLICATIONS LTD, pp. 84 - 84, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000328855900194&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Accurate prediction of response to HIV therapy without a genotype: a potential tool for therapy optimization in resource-limited settings', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CANADA, Toronto, pp. A20 - A20, presented at International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, CANADA, Toronto, 04 June 2013 - 08 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335229500016&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2013, 'Proviral DNA testing of HIV tropism in the Maraviroc Switch Collaborative Study (MARCH) - results of a three-phase quality assurance (QA) programme', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CANADA, Toronto, pp. A144 - A144, presented at International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, CANADA, Toronto, 04 June 2013 - 08 June 2013, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000335229500117&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2011, 'LOWER FAT MASS AND LOWER BONE FORMATION PREDICT GREATER BONE LOSS WITH TENOFOVIR IN HIV-INFECTED ADULTS', in OSTEOPOROSIS INTERNATIONAL, SPRINGER LONDON LTD, AUSTRALIA, Gold Coast, pp. S614 - S615, presented at IOF Regionals 2nd Asia-Pacific Osteoporosis and Bone Meeting / ANZBMS Annual Scientific Meeting held with the JSBMR, AUSTRALIA, Gold Coast, 04 September 2011 - 08 September 2011, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000309258200234&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Predictors of limb fat changes in patients switched to tenofovir-emtricitabine or abacavir-lamivudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A7 - A7, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431200022&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Predictors of limb fat changes in patients switched to tenofovir-emtricitabine or abacavir-lamivudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A7 - A7, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431500008&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'The development of computational models that accurately predict virological response to HIV therapy to power an online treatment selection tool', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CROATIA, Dubrovnik, pp. A89 - A89, presented at Workshop on International HIV and Hepatitis Virus Drug Resistance and Curative Strategies, CROATIA, Dubrovnik, 08 July 2010 - 12 July 2010, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000287431300076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'The development of computational models that accurately predict virological response to HIV therapy to power an online treatment selection tool', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Dubrovnik, CROATIA, pp. A89 - A89, presented at International HIV and Hepatitis Virus Drug Resistance and Curative Strategies Workshop, Dubrovnik, CROATIA, 08 June 2010 - 12 June 2010, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000280215800091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'Anthropometric and metabolic outcomes in a 48-week randomized, open-label study of three different combination antiretroviral regimens as initial therapy for HIV infection', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, PA, Philadelphia, pp. A8 - A9, presented at 11th International Workshop on AdverseDrug Reactions and Co-Morbidities in HIV, PA, Philadelphia, 26 October 2009 - 28 October 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000272060000026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir in randomized trials: systematic review and meta-analysis', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, PA, Philadelphia, pp. A58 - A58, presented at 11th International Workshop on AdverseDrug Reactions and Co-Morbidities in HIV, PA, Philadelphia, 26 October 2009 - 28 October 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000272060000079&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'Computational models developed without a genotype for resource-poor countries predict response to HIV treatment with 82% accuracy', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, FL, Ft Myers, pp. A38 - A38, presented at 18th International HIV Drug Resistance Workshop, FL, Ft Myers, 09 June 2009 - 13 June 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000268039900053&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial', in The Lancet, pp. 1881 - 1893, http://dx.doi.org/10.1016/S0140-6736(08)61591-3
,2006, 'Metabolic syndrome in HIV-infected patients using IDF and ATPIII criteria: prevalence, discordance and clinical utility', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CA, San Francisco, pp. L4 - L4, presented at 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CA, San Francisco, 24 September 2006 - 26 September 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241975800023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2006, 'Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV-infected adults', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CA, San Francisco, pp. L4 - L4, presented at 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CA, San Francisco, 24 September 2006 - 26 September 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241975800024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2005, 'Clinically relevant breakpoints for virco (R) TYPE HIV-1 phenotypic resistance information', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CANADA, Quebec City, pp. S39 - S39, presented at 14th International HIV Drug Resistance Workshop, CANADA, Quebec City, 07 June 2005 - 11 June 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000232470800040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2004, 'Estimation of phenotypic clinical cutoffs for VirtualPhenotype (TM) through meta analyses of clinical trial and cohort data', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, SPAIN, Tenerife, pp. U108 - U109, presented at 13th International HIV Drug Resistance Workshop, SPAIN, Tenerife, 08 June 2004 - 12 June 2004, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000231615600162&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2004, 'Evaluation of different approaches for the definition of clinically relevant breakpoints for phenotypic resistance data', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, SPAIN, Tenerife, pp. U92 - U92, presented at 13th International HIV Drug Resistance Workshop, SPAIN, Tenerife, 08 June 2004 - 12 June 2004
,2003, 'HIV Lipodystrophy Case Definition Study Group. Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, pp. 57 - 57
,2003, 'Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, pp. L73 - L73
,2002, 'Haematological changes in patients randomized to HAART regimens containing either zidovudine or stavudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CALIFORNIA, SAN DIEGO, pp. L60 - L60, presented at 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CALIFORNIA, SAN DIEGO, 22 September 2002 - 25 September 2002, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000179501500101&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1999, 'Immune reconstitution in HIV infection', in AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT INC PUBL, pp. 1600 - 1600, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000084146700005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1998, 'A phase II study of subcutaneous (SC) IL-2 plus antiretrovirals (ARV) vs ARV alone in patients with HIV infection and CD4+ cell count >= 350/MM3.', in AIDS, LIPPINCOTT WILLIAMS & WILKINS, pp. S65 - S65, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000077311300251&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1991, 'DISTURBANCES OF LIPID-PEROXIDATION IN RAT-LIVER CANCER-CELLS AND IN NORMAL REGENERATING RAT-LIVER', in Nigam S; Honn KV; Marnett LJ; Walden TL (eds.), EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RADIATION-INJURY, KLUWER ACADEMIC PUBLISHERS, GERMANY, FREE UNIV BERLIN, UNIVESSITATSKLINIKUM STEGITZ, BERLIN, pp. 81 - 88, presented at 2ND INTERNATIONAL CONF ON EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RADIATION INJURY, GERMANY, FREE UNIV BERLIN, UNIVESSITATSKLINIKUM STEGITZ, BERLIN, 17 September 1991 - 21 September 1991, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993BX34U00019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1988, 'LIPID-PEROXIDATION IN LIVER-TUMORS AND REGENERATING LIVER', in POLI G; CHEESEMAN KH; DIANZANI MU; SLATER TF (eds.), FREE RADICALS IN THE PATHOGENESIS OF LIVER INJURY, PERGAMON PRESS LTD, ITALY, TURIN, pp. 165 - 175, presented at 2ND CONGRESS ON FREE RADICALS IN LIVER INJURY, ITALY, TURIN, 09 June 1988 - 11 June 1988, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1989BR17D00018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,